196 related articles for article (PubMed ID: 19297609)
1. Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines.
Yao Y; Zhao Y; Smith LP; Lawrie CH; Saunders NJ; Watson M; Nair V
J Gen Virol; 2009 Jul; 90(Pt 7):1551-1559. PubMed ID: 19297609
[TBL] [Abstract][Full Text] [Related]
2. Marek's Disease Virus-Encoded MicroRNA 155 Ortholog Critical for the Induction of Lymphomas Is Not Essential for the Proliferation of Transformed Cell Lines.
Zhang Y; Tang N; Luo J; Teng M; Moffat K; Shen Z; Watson M; Nair V; Yao Y
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189706
[TBL] [Abstract][Full Text] [Related]
3. Targeted Deletion of Glycoprotein B Gene by CRISPR/Cas9 Nuclease Inhibits
Zhang Y; Li W; Tang N; Moffat K; Nair V; Yao Y
J Virol; 2022 Mar; 96(6):e0202721. PubMed ID: 35107377
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the mRNA targetome of microRNAs expressed by Marek's disease virus.
Parnas O; Corcoran DL; Cullen BR
mBio; 2014 Jan; 5(1):e01060-13. PubMed ID: 24449754
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs 221 and 222 target p27Kip1 in Marek's disease virus-transformed tumour cell line MSB-1.
Lambeth LS; Yao Y; Smith LP; Zhao Y; Nair V
J Gen Virol; 2009 May; 90(Pt 5):1164-1171. PubMed ID: 19264608
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles of microRNAs encoded by the oncogenic Marek's disease virus reveal two distinct expression patterns in vivo during different phases of disease.
Luo J; Sun AJ; Teng M; Zhou H; Cui ZZ; Qu LH; Zhang GP
J Gen Virol; 2011 Mar; 92(Pt 3):608-20. PubMed ID: 21148277
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs.
Yao Y; Zhao Y; Xu H; Smith LP; Lawrie CH; Watson M; Nair V
J Virol; 2008 Apr; 82(8):4007-15. PubMed ID: 18256158
[TBL] [Abstract][Full Text] [Related]
8. A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.
Lian L; Qu L; Chen Y; Lamont SJ; Yang N
PLoS One; 2012; 7(11):e51003. PubMed ID: 23226446
[TBL] [Abstract][Full Text] [Related]
9. Marek's disease virus-induced immunosuppression: array analysis of chicken immune response gene expression profiling.
Heidari M; Sarson AJ; Huebner M; Sharif S; Kireev D; Zhou H
Viral Immunol; 2010 Jun; 23(3):309-19. PubMed ID: 20565294
[TBL] [Abstract][Full Text] [Related]
10. MiRNA expression signatures induced by Marek's disease virus infection in chickens.
Tian F; Luo J; Zhang H; Chang S; Song J
Genomics; 2012 Mar; 99(3):152-9. PubMed ID: 22178800
[TBL] [Abstract][Full Text] [Related]
11. Current state of Marek's disease virus microRNA research.
Hicks JA; Liu HC
Avian Dis; 2013 Jun; 57(2 Suppl):332-9. PubMed ID: 23901744
[TBL] [Abstract][Full Text] [Related]
12. Selection of a recombinant Marek's disease virus in vivo through expression of the Marek's EcoRI-Q (Meq)-encoded oncoprotein: characterization of an rMd5-based mutant expressing the Meq of strain RB-1B.
Kumar P; Dong H; Lenihan D; Gaddamanugu S; Katneni U; Shaikh S; Tavlarides-Hontz P; Reddy SM; Peters W; Parcells MS
Avian Dis; 2012 Jun; 56(2):328-40. PubMed ID: 22856190
[TBL] [Abstract][Full Text] [Related]
13. Virus-encoded miR-155 ortholog in Marek's disease virus promotes cell proliferation via suppressing apoptosis by targeting tumor suppressor WWOX.
Zhu ZJ; Teng M; Li HZ; Zheng LP; Liu JL; Yao Y; Nair V; Zhang GP; Luo J
Vet Microbiol; 2021 Jan; 252():108919. PubMed ID: 33191002
[TBL] [Abstract][Full Text] [Related]
14. gga-miR-26a targets NEK6 and suppresses Marek's disease lymphoma cell proliferation.
Li X; Lian L; Zhang D; Qu L; Yang N
Poult Sci; 2014 May; 93(5):1097-105. PubMed ID: 24795301
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
16. Differentially expressed genes during spontaneous lytic switch of Marek's disease virus in lymphoblastoid cell lines determined by global gene expression profiling.
Mwangi WN; Vasoya D; Kgosana LB; Watson M; Nair V
J Gen Virol; 2017 Apr; 98(4):779-790. PubMed ID: 28475033
[TBL] [Abstract][Full Text] [Related]
17. Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.
Burgess SC; Davison TF
J Virol; 2002 Jul; 76(14):7276-92. PubMed ID: 12072527
[TBL] [Abstract][Full Text] [Related]
18. Impact of HVT Vaccination on Splenic miRNA Expression in Marek's Disease Virus Infections.
Hicks JA; Liu HC
Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30764490
[TBL] [Abstract][Full Text] [Related]
19. Effect of gga-miR-155 on cell proliferation, apoptosis and invasion of Marek's disease virus (MDV) transformed cell line MSB1 by targeting RORA.
Ding K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC; Zhou ZY; Yu ZL
BMC Vet Res; 2020 Jan; 16(1):23. PubMed ID: 31992293
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effects of gga-miR-199-3p, gga-miR-140-3p, and gga-miR-221-5p in Marek's disease tumorigenesis.
Lian L; Zhang D; Wang Q; Yang N; Qu L
Poult Sci; 2015 Sep; 94(9):2131-5. PubMed ID: 26112035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
